col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


58 Results       Page 1

 [1] 
Ovid: Circulation Research
  original article Date Title Authors   All Authors
1 [GO] 2024―Oct―09 Abstract We127: Infective Endocarditis in COVID-19 - An Unusual Suspect Sean Masi, Darshine Venugopal, Stefanie Delvecchio
2 [GO] 2024―Oct―09 Abstract We126: Myocarditis Following mRNA Vaccination for COVID-19 is Mediated by CXCL10 and IFN-γ Xu Cao, Masataka Nishiga, Amit Manhas, Arianne Caudal, Gema Mondejar-Parreno, Shane Zhao, et al. (+5)
3 [GO] 2024―Oct―09 Abstract We128: Effect of Coronavirus Disease 2019 on the Incidence of Stress-induced Cardiomyopathy; A Single Center Experience Fawaz Mohammed, Zaina Ali Khan, Muna Mohammed, James Gubitosa, Anna H. Cox, Ahmed D. Kamaluldeen, et al. (+11)
4 [GO] 2024―May―30 Neutrophil Cathepsin G and Thrombosis in COVID-19 Francesco Violi, Simona Bartimoccia, Roberto Cangemi, Cristina Nocella, Alessandra D’Amico, Alessandra Oliva, et al. (+11)
5 [GO] 2023―Oct―13 Abstract P2189: Role Of Innate Immune Response And Mitochondrial Ros In The Cardiac And Pulmonary Sequelae Of Covid-19 Ting Liu, Deepthi Ashok, Morgan Craney, Amanda Wong, D B Foster, Andrew Pekosz, et al. (+2)
6 [GO] 2023―Oct―13 Abstract P2194: Investigating The Role Of Angiotensin II In The Pathogenesis Of Atrial Fibrillation In Covid-19 Patients Through Blocking The Renin-Angiotensin-Aldosterone System Angela Khidhir, Thomas Drago, Usman Najam, Sourabh Goyal, Michael Beshara, Leonard Palatnic, Brian Chatterton
7 [GO] 2023―Oct―13 Abstract P2188: Covid-19 Plasma Exposure Causes Transcriptional, Morphological, And Functional Changes Within The Pulmonary Microvascular Endothelium Rainha Passi, Justyna Cholewa-Waclaw, Ryan Wereski, Stefan Veizades, Matthew Bennett, Brownwyn Berkeley, et al. (+8)
8 [GO] 2023―Oct―13 Abstract P3164: Podocalyxin, A Renal Podocyte Specific Protein Expression In Urine Exosome Acts As A Marker For Podocyte Injury During Sars-cov-2 Infection Seshagiri Rao R Nandula, Sabyasachi Sen
9 [GO] 2023―Oct―13 Abstract P2192: Growth Hormone-releasing Hormone Receptor Antagonist Attenuates Cardiopulmonary Injury Induced By A Bsl2 Rvsv-sars-cov-2-s Virus Mimic Of Sars-cov-2 Infectivity Jose Manuel Condor Capcha, Ali Kamiar, Emely Robleto, Tengjiao Cui, Ali Saad, Amanda Wong, et al. (+7)
10 [GO] 2023―Oct―13 Abstract P2195: SARS-CoV-2 Variants Divergently Infect And Damage Cardiomyocytes Bobo Mok, Maxwell Kwok, Hung Sing Li, Lowell Ling, Angel Lai, Paul Chan, et al. (+3)
11 [GO] 2023―Oct―13 Abstract P2187: SARS-CoV2 Nonstructural Protein, But Not The Omicron Ba.4/5 Mutant, Suppresses YAP Transcriptional Activity In The Heart Fansen Meng, Chang-Ru Tsai, Jong H Kim, Xiao Li, Jeff Steimle, Shijie Liu, et al. (+3)
12 [GO] 2023―Jul―20 Correction to: Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations
13 [GO] 2023―Jun―22 Correction to: Cell-Specific Mechanisms in the Heart of COVID-19 Patients
14 [GO] 2023―May―11 COVID-19, Myocarditis and Pericarditis DeLisa Fairweather, Danielle J. Beetler, Damian N. Di Florio, Nicolas Musigk, Bettina Heidecker, Leslie T. Cooper
15 [GO] 2023―May―11 Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations Rui-Sheng Wang, Joseph Loscalzo
16 [GO] 2023―May―11 Cell-Specific Mechanisms in the Heart of COVID-19 Patients Emily J. Tsai, Daniela Cˇiháková, Nathan R. Tucker
17 [GO] 2023―May―11 Platelets and SARS-CoV-2 During COVID-19: Immunity, Thrombosis, and Beyond Anthony Sciaudone, Heather Corkrey, Fiachra Humphries, Milka Koupenova
18 [GO] 2023―May―11 Interaction of COVID-19 With Common Cardiovascular Disorders Peter K. Boulos, Scott V. Freeman, Timothy D. Henry, Ehtisham Mahmud, John C. Messenger
19 [GO] 2023―May―11 COVID-19 and the Cardiovascular System: Requiem for a Medical Minotaur Milka Koupenova, Mina K. Chung, Michael R. Bristow
20 [GO] 2023―May―11 Microfluidic Organ-Chips and Stem Cell Models in the Fight Against COVID-19 Sandro Satta, Sarah J. Rockwood, Kaidong Wang, Shaolei Wang, Maedeh Mozneb, Madelyn Arzt, et al. (+2)
21 [GO] 2023―May―11 Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment Mark C. Chappell
22 [GO] 2023―May―11 A Post-Pandemic Enigma: The Cardiovascular Impact of Post-Acute Sequelae of SARS-CoV-2 Tamanna K. Singh, David A. Zidar, Keith McCrae, Kristin B. Highland, Kristin Englund, Scott J. Cameron, Mina K. Chung
23 [GO] 2023―Jan―13 Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection Roberto Carnevale, Vittoria Cammisotto, Simona Bartimoccia, Cristina Nocella, Valentina Castellani, Marianna Bufano, et al. (+15)
24 [GO] 2022―Nov―14 Abstract P3121: Serological Mechanisms Driving Cardiotoxicity In Covid-19 Maria T Colzani, Johannes Bargehr, Federica Mescia, Vincent Knight-Schrijver, Charlotte Summers, Kenneth G Smith, et al. (+2)
25 [GO] 2022―Nov―14 Abstract P3119: Selectively Expressing Sars-Cov-2 Spike Protein S1 Subunit In Cardiomyocytes Induces Cardiac Hypertrophy In Mice Caroline Sheldon, Steven Negron, Chase W Kessinger, Bing Xu, William T Pu, Chieh-Yu Lin, Zhiqiang Lin
26 [GO] 2022―Oct―21 Persisting Platelet Activation and Hyperactivity in COVID-19 Survivors Platelet Activation in COVID-19 Survivors Remy Martins-Gonçalves, Mariana Campos, Lohanna Palhinha, Isaclaudia G. Azevedo-Quintanilha, Mayara Abud Mendes, Jairo Ramos Temerozo, et al. (+6)
27 [GO] 2022―Apr―28 Vascular Aging After COVID-19: A Story of Lasting Injury or Prolonged Healing? Leili Behrooz, Jennifer E. Ho, Naomi M. Hamburg
28 [GO] 2022―Apr―14 Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination Manuela De Michele, Joshua Kahan, Irene Berto, Oscar G. Schiavo, Marta Iacobucci, Danilo Toni, Alexander E. Merkler
29 [GO] 2022―Mar―31 Ferroptosis of Pacemaker Cells in COVID-19 Masataka Nishiga, James W.S. Jahng, Joseph C. Wu
30 [GO] 2022―Mar―29 Vascular Dysfunction of COVID-19 Is Partially Reverted in the Long-Term Luca Zanoli, Agostino Gaudio, Dimitri P. Mikhailidis, Niki Katsiki, Niccolò Castellino, Lorenzo Lo Cicero, et al. (+27)
31 [GO] 2022―Mar―08 SARS-CoV-2 Infection Induces Ferroptosis of Sinoatrial Node Pacemaker Cells Yuling Han, Jiajun Zhu, Liuliu Yang, Benjamin E. Nilsson-Payant, Romulo Hurtado, Lauretta A. Lacko, et al. (+13)
32 [GO] 2021―Nov―22 Abstract P357: Induction Of Soluble P-selectin And CD40 Ligand And, FXIII Deficiency Promote Aberrant Coagulation And Thromboembolism In Severe COVID-19 Abaher O Al-Tamimi, Ayesha M Yusuf, Manju N Jayakumar, Abdul W Ansari, Mona Elhassan, Fatema AbdulKarim, et al. (+3)
33 [GO] 2021―Nov―22 Abstract P508: Hyperglycemia Exacerbated Sars-cov-2 Spike Protein-induced Electrophysiological Dysfunctions In Hipsc-derived Cardiomyocytes Chloe Wong, Thong B Nguyen, Michael Tong, Takashi Matsui, Yiqiang Zhang
34 [GO] 2021―Nov―22 Abstract 112: The 3CL Protease Of SARS-CoV2 Induces Sarcomeric Degradation Through Cleavage Of The Giant Protein Obscurin Nora Yucel, Quentin McAfee, Maria G Paterlini, Zoltan Arany
35 [GO] 2021―Sep―02 Are Platelets SARS-CoV-2’s “Dead End”? Kara L. Gawelek, Elisabeth M. Battinelli
36 [GO] 2021―Jul―23 SARS-CoV-2 Initiates Programmed Cell Death in Platelets Milka Koupenova, Heather A Corkrey, Olga Vitseva, Kahraman Tanriverdi, Mohan Somasundaran, Ping Liu, et al. (+11)
37 [GO] 2021―Jul―09 Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in Covid-19 Duco Koenis, Issa Beegun, Charlotte Jouvene, Gabriel Amador Aguirre, Patricia R Souza, Maria Gonzalez-Nunez, et al. (+9)
38 [GO] 2021―Jun―24 Macrophages: Potential Therapeutic Target of Myocardial Injury in COVID-19 Masataka Nishiga, Joseph C. Wu
39 [GO] 2021―Apr―15 COVID-19 and Cardiovascular Disease Mina K. Chung, David A. Zidar, Michael R. Bristow, Scott J. Cameron, Timothy Chan, Clifford V. Harding, et al. (+7)
40 [GO] 2021―Apr―15 An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts Liuliu Yang, Yuling Han, Fabrice Jaffre, Benjamin E Nilsson-Payant, Yaron Bram, Pengfei Wang, et al. (+18)
41 [GO] 2021―Apr―01 Hypertension, a Moving Target in COVID-19 Carmine Savoia, Massimo Volpe, Reinhold Kreutz
42 [GO] 2021―Mar―31 SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE2 Yuyang Lei, Jiao Zhang, Cara R Schiavon, Ming He, Lili Chen, Hui Shen, et al. (+15)
43 [GO] 2020―Nov―05 Platelets and COVID-19 Milka Koupenova, Jane E. Freedman
44 [GO] 2020―Sep―17 Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19 Younes Zaid, Florian Puhm, Isabelle Allaeys, Abdallah Naya, Mounia Oudghiri, Loubna Khalki, et al. (+14)
45 [GO] 2020―Aug―27 Correction to: Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19
46 [GO] 2020―Aug―06 Biomarkers of Platelet Activity and Vascular Health Associate with Thrombosis and Mortality in Patients with COVID-19 Tessa J Barrett, Angela Lee, Yuhe Xia, Lawrence H Lin, Margaret Black, Paolo Cotzia, et al. (+2)
47 [GO] 2020―Jul―02 Letter by Weir Regarding Article, “Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2” Robin A.P. Weir
48 [GO] 2020―Jul―02 Response by Gheblawi et al to Letter Regarding Article, “Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2” Mahmoud Gheblawi, Kaiming Wang, Anissa Viveiros, Quynh Nguyen, Jiu-Chang Zhong, Anthony J. Turner, et al. (+3)
49 [GO] 2020―Jun―26 The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications James D McFadyen, Hannah Stevens, Karlheinz Peter
50 [GO] 2020―Jun―08 Hypoalbuminemia, Coagulopathy and Vascular Disease in Covid-19 Francesco Violi, Giancarlo Ceccarelli, Roberto Cangemi, Francesco Alessandri, Gabriella d'Ettorre, Alessandra Oliva, et al. (+7)
51 [GO] 2020―Jun―04 Response by Zhang et al to Letter Regarding Article, “Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19” Peng Zhang, Lihua Zhu, Jingjing Cai, Fang Lei, Juan-Juan Qin, Yibin Wang, et al. (+4)
52 [GO] 2020―Jun―04 Response by Cohen et al to Letter Regarding Article, “Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19” Jordana B. Cohen, Thomas C. Hanff, Andrew M. South, Matthew A. Sparks, Swapnil Hiremath, Adam P. Bress, et al. (+2)
53 [GO] 2020―May―07 SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China: Insights from the ERS-COVID-19 Study Dongze Li, You Chen, Yu Jia, Le Tong, Jiale Tong, Wei Wang, et al. (+4)
54 [GO] 2020―Apr―17 Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 Peng Zhang, LiHua Zhu, Jingjing Cai, Fang Lei, Juan-Juan Qin, Jing Xie, et al. (+38)
55 [GO] 2020―Apr―17 ACEing COVID-19: A Role For Angiotensin Axis Inhibition in SARS-CoV-2 infection? Ravi Shah, Venkatesh L. Murthy, Milka Koupenova
56 [GO] 2020―Apr―08 Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System Mahmoud Gheblawi, Kaiming Wang, Anissa Viveiros, Quynh Nguyen, Jiu-Chang Zhong, Anthony J Turner, et al. (+3)
57 [GO] 2020―Apr―07 COVID-19 and the Heart Akbarshakh Akhmerov, Eduardo Marban
58 [GO] 2020―Feb―27 Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases Jingjing Cai, Xiao-Jing Zhang, Yan-Xiao Ji, Peng Zhang, Zhi-Gang She, Hongliang Li
 [1] 

58 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec